The 2023 Orthopedic Research Society's international consensus meeting on musculoskeletal infection: Summary from the in vitro section

Author:

Hickok Noreen J.1ORCID,Li Bingyun2ORCID,Oral Ebru3ORCID,Zaat Sebastian A. J.4ORCID,Armbruster David A.5,Atkins Gerald J.6ORCID,Chen Antonia F.7ORCID,Coraça‐Huber Débora C.8ORCID,Dai Tianhong9,Greenfield Edward M.10,Kasinath Rajendra11,Libera Matthew12,Marques Cláudia N. H.13,Moriarty T. Fintan14ORCID,Scott Phillips K.15,Raghuraman Kapil16,Ren Dacheng17,Rimondini Lia18,Saeed Kordo1920ORCID,Schaer Thomas P.21ORCID,Schwarz Edward M.22ORCID,Spiegel Christopher23,Stoodley Paul24ORCID,Truong Vi Khanh25,Tsang Shao‐Ting Jerry26,Wildemann Britt27ORCID,Zelmer Anja R.6,Zinkernagel Annelies S.28

Affiliation:

1. Department of Orthopaedic Surgery, Department of Biochemistry & Molecular Biology Thomas Jefferson University Philadelphia Pennsylvania USA

2. Department of Orthopaedics, School of Medicine West Virginia University Morgantown West Virginia USA

3. Harris Orthopaedic Laboratory, Department of Orthopaedic Surgery, Harvard Medical School Massachusetts General Hospital Boston Massachusetts USA

4. Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

5. DePuy Synthes Biomaterials West Chester Pennsylvania USA

6. Centre for Orthopaedic and Trauma Research University of Adelaide Adelaide South Australia Australia

7. Department of Orthopaedics, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

8. Research Laboratory for Implant Associated Infections (Biofilm Lab), University Hospital for Orthopedics and Traumatology, Experimental Orthopaedics Medical University of Innsbruck Innsbruck Austria

9. Harvard Medical School, Wellman Center for Photomedicine Massachusetts General Hospital Boston Massachusetts USA

10. Department of Orthopaedic Surgery, Indiana University School of Medicine Indiana Center for Musculoskeletal Health Indianapolis Indiana USA

11. DePuy Synthes Biomaterials Warsaw Indiana USA

12. Department of Chemical Engineering and Materials Science Stevens Institute of Technology Hoboken New Jersey USA

13. Department of Biological Sciences, Binghamton Biofilm Research Center Binghamton University Binghamton New York USA

14. AO Research Institute Davos Davos Switzerland

15. Laboratory of Analytical Chemistry, Division of Biological Standards and Quality Control, Office of Compliance and Biologics Quality, Center for Biologics Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

16. Enovis Austin Texas USA

17. Department of Biomedical and Chemical Engineering Syracuse University Syracuse New York USA

18. Department of Health Sciences Università del Piemonte Orientale Novara Italy

19. University Hospital Southampton NHS Foundation Trust Winchester and Basingstoke UK

20. University of Southampton Southampton UK

21. Department of Clinical Studies, New Bolton Center University of Pennsylvania Kennett Square Pennsylvania USA

22. Center for Musculoskeletal Research University of Rochester Rochester New York USA

23. Research Laboratory for Biofilms and Implant Associated Infections (BIOFILM LAB), Experimental Orthopedics, University Hospital for Orthopedics and Traumatology Medical University of Innsbruck Innsbruck Austria

24. Department Microbial Infection and Immunity and Department of Orthopaedics The Ohio State University Columbus Ohio USA

25. Biomedical Nanoengineering Laboratory College of Medicine and Public Health Bedford Park South Australia Australia

26. Department of Trauma and Orthopaedic Surgery University of Edinburgh Edinburgh Scotland UK

27. Experimental Trauma Surgery, Department of Trauma, Hand and Reconstructive Surgery, Jena University Hospital Friedrich Schiller University Jena Jena Germany

28. Department of Infectious Diseases and Hospital Epidemiology University Hospital of Zurich and University of Zurich Zurich Switzerland

Abstract

AbstractAntimicrobial strategies for musculoskeletal infections are typically first developed with in vitro models. The In Vitro Section of the 2023 Orthopedic Research Society Musculoskeletal Infection international consensus meeting (ICM) probed our state of knowledge of in vitro systems with respect to bacteria and biofilm phenotype, standards, in vitro activity, and the ability to predict in vivo efficacy. A subset of ICM delegates performed systematic reviews on 15 questions and made recommendations and assessment of the level of evidence that were then voted on by 72 ICM delegates. Here, we report recommendations and rationale from the reviews and the results of the internet vote. Only two questions received a ≥90% consensus vote, emphasizing the disparate approaches and lack of established consensus for in vitro modeling and interpretation of results. Comments on knowledge gaps and the need for further research on these critical MSKI questions are included.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3